Hyperglycemic Emergencies DKA/HONC - PowerPoint PPT Presentation

About This Presentation
Title:

Hyperglycemic Emergencies DKA/HONC

Description:

Hyperglycemic Emergencies DKA/HONC William Harper, MD, FRCPC Endocrinology & Metabolism Assistant Professor of Medicine, McMaster University Case 40 y.o. male, T1DM x ... – PowerPoint PPT presentation

Number of Views:364
Avg rating:3.0/5.0
Slides: 38
Provided by: wiliamlou
Category:

less

Transcript and Presenter's Notes

Title: Hyperglycemic Emergencies DKA/HONC


1
Hyperglycemic EmergenciesDKA/HONC
  • William Harper, MD, FRCPC
  • Endocrinology Metabolism
  • Assistant Professor of Medicine, McMaster
    University

2
Case
  • 40 y.o. male, T1DM x 20y
  • Normally on Novolin 30/70 38/20
  • Presents with decr LOC, confusion
  • 80/60, P120 reg, JVP lt SA, dry mucus mem
  • RR 32, fruity odor to breath
  • CBG 39 mM

3
Case
  • 85 160
  • 3.1 18 21
  • 7.2933189598
  • What are the acid-base disturbances?

42 BS
4
Case
  • 85 160
  • 3.1 18 21
  • 7.2933189598
  • What other tests need to be done?

42 BS
5
DKA
  • A collection of severe and potentially
    life-threatening metabolic disturbances
  • Hyperglycemia ? Osmotic diuresis
  • Urinary loss of fluids electrolytes
  • ECFv contraction
  • Depletion of total body K stores
  • (even though may be hyperkalemic 2 to cell
    shift)
  • Ketone production ? Metabolic acidosis
  • Compensatory Respiratory alkalosis (hopefully!)
  • Uncontrolled lipolysis ? severe ? TG

6
DKA Pathophysiology
fat cell TG
Insulin -
Ketoacids
Glucose
HSL
FFA
PFK
Insulin
Liver Cell
Pyruvate
Fatty Acyl-CoA
Acetyl-CoA

Krebs
Glucagon Insulin

VLDL (TG)
7
DKA Pathophysiology
fat cell TG
Insulin -
Ketoacids
Glucose
HSL
FFA
PFK
Insulin
Liver Cell
Pyruvate
Fatty Acyl-CoA
Acetyl-CoA

Krebs
Glucagon Insulin

VLDL (TG)
8
DKA risk factors
  • T1DM
  • 1st presentation
  • Acute-illness
  • Insulin omission (inappropriate sick-day
    management, noncompliance, Eating Disorders)
  • T2DM
  • During stress
  • Ethnicity African-American, Hispanic
  • Extremes of age
  • Poor glycemic control
  • MDI with CSII

9
DKA Precipitating Factors
Acute illness
(MI, GIB, trauma,
10-20
pancreatitis)
20-38
New-onset DM
5-39
Insulin omission
33
Infections
10
DKA Diagnosis
  • Symptoms Signs
  • Polyuria, polydipsia, weight-loss
  • Fatigue
  • N/V, abdominal pain
  • ? ECFv, Kussmauls, Acetone breath, mild
    impairment in cognition
  • Laboratory
  • pH lt 7.3, serum HCO3 lt 15 mEq/L, AG gt 14 mM
  • Raised serum ketones (and urine ketones)
  • BS gt 14 mM (occasionally normal or only mild ?
    BS)

11
DKA Management
  • Monitoring
  • IV Fluid Resuscitation (3-9L deficit)
  • Potassium (no pee no K)
  • K deficit 3-5 mEq/Kg
  • IV insulin
  • Identify Rx underlying cause
  • Noncompliance, infection, MI, etc.

12
DKA Monitoring
  • Consider ICU
  • pH lt 6.9, inadequate respiratory compensation
  • decreased LOC
  • Severe K disturbance (K lt 3.0 or gt 6.0 mEq/L)
  • Stepdown/Telemetry all others
  • Ward
  • Only very mild DKA!
  • pH gt 7.2, serum HCO3 gt 20, AG lt 14
  • ECFv near normal
  • Not elderly, no hi-risk DKA precipitant (ex. MI)

13
DKA Monitoring
  • CBG q1-2h on IV insulin gtt
  • q2h Serum lytes, creatinine, glucose
  • q4-6h
  • pH gt 7.2, HCO3 gt 20, AG lt 15
  • ECFv stable and IV fluids _at_ maintenance rates
  • normal K
  • Calcium profile
  • Initially, then q12-24h unless abnormal
  • Phospate levels can be high at 1st but drop with
    Rx of DKA
  • Flowcharts to record biochemical parameters shown
    to be useful

14
DKA Monitoring
  • EKG, cardiac enzymes r/o ACS (silent MI)
  • Septic w/up cultures, CXR, urinalysis, etc.
  • Consider pulmonary embolism?

15
DKA IV Fluids
  • IV NS 0.5-1L/h x 1-2h or longer so no more
    tachycardia, hypotension, orthostatic changes,
    low JVP.
  • Then change to 1/2 NS
  • 200-500 cc/h over 12h in order to replace ½
    estimated deficit
  • Then lower to 100-150 cc/h until deficit restored
    and eating/drinking well
  • If hypotension recalcitrant to fluids consider AI
    (Schmidt PGAS II) and send stat plasma cortisol
    and ACTH, then give solucortef 100 mg IV q8h.

16
DKA Mortality
  • Adults 2-4
  • Hypokalemia
  • MI, CVA, penumonia, pulm embolism, etc.
  • Kids 0.2-0.4
  • Cerebral edema

17
DKA Potassium
  • K defecit 3-5 mEq/Kg (350 mEq for 70Kg)
  • Normal to high serum K

Ketoacidosis
H
H
K
K
Insulin
18
DKA Potassium
  • K deficit 3-5 mEq/kg (350 mEq 70kg)
  • Need K with initial IV fluid insulin Rx unless
  • Anuric
  • K gt 5.5 mEq/L or hyperkalemic ECG changes

Initial K Replacement
gt 5.5 mEq/L nil (initially)
5.2-5.5 mEq/L 10 mEq/h
4-5.2 mEq/L 20 mEq/h
3-4 mEq/L 30 mEq/h
lt 3 mEq/L 40 mEq/h
gt 20 mEq/h Cardiac monitor gt 60 mEq/L Central
line
19
DKA IV Insulin
  • Might delay starting IV insulin for a few hours
    if K severely low (lt 3.0 mEq/L) and metabolic
    acidosis not severe (pH gt 7.0)
  • Humulin R or Novolin Toronto
  • Bolus 0.1-0.2 U/kg IV
  • Then IV gtt _at_ 0.1-0.2 U/kg/h
  • (50 U of regular insulin in 500cc D5W
    1U/10cc)
  • Aim is to demonstrate correction of Anion Gap
    (AG) and decrease in BS 4.4 mM/L/h
  • Monitoring serial serum ketones NOT useful as
    most assays measure Acetoacetate only
  • ßHß (not detected) DKA Rx Acetoacetate
    (detected)

20
DKA IV Insulin
  • Using insulin to treat 2 different and separate
    metabolic disturbances in DKA
  • Ketoacidosis
  • Hyperglycemia

21
DKA IV Insulin
  • If AG not correcting and/or BS not decreasing
    then increase IV gtt rate 1.5-2X
  • If BS lt 13 but AG still not corrected do NOT
    decrease insulin IV gtt.
  • Instead start IV glucose gtt
  • D5W-D10W _at_ 100-200 cc/h
  • Once AG corrected than titrate IV insulin to BS
  • When BS lt 13 and AG normal reduce IV insulin gtt
    to 1-2 U/h and add IV glucose if not already done.

22
DKA Switch to S.C. insulin
  • Can consider switch to SC insulin when
  • AG normalized
  • BS lt 15 mM
  • Insulin IV gtt requirements lt 2U/h
  • Patient able to eat
  • Overlap insulin IV gtt with 1st SC insulin by
    2-4h to avoid recurrent ketosis
  • T2DM patients with DKA
  • Dont necessarily have to be d/c on insulin SC (I
    often do!)
  • Once acute stress resolved, many do well on OHA

23
DKA Other Rx
  • Bicarbonate
  • May exacerbate hypokalemia
  • Only give if pH lt 6.9 AND evidence of
    cardiovascualr instability (arrythmia, CHF,
    hypotension)
  • 1-2 amps bicarb in 1L D5W IV with 10-20 mEq of
    added KCl given over 2h or until pH gt 7.1
  • Phosphate
  • Routine IV not recommended
  • Rx symptomatic hypophosphatemia (rhabdo,
    unexplained CHF or respiratory failure, severe
    confusion)
  • 10cc K Phos soln (3.0mEq Pi and 4.4 mEq K/cc) in
    1L NS IV over 8-12h

24
DKA Other Rx
  • Cerebral Edema
  • Usually only kids
  • Persistent decreased LOC despite standard Rx of
    DKA
  • CT scan to confirm diagnosis
  • Decadron 10 mg IV
  • Mannitol 25 mg IV

25
DKA Management
  • Monitoring
  • ICU pH lt 6.9, severe K (lt 3, gt 6), decr LOC
  • IV Fluid Resuscitation (3-9L deficit)
  • Potassium (no pee no K)
  • IV insulin
  • Identify Rx underlying cause
  • Noncompliance, infection, MI, etc.

26
(No Transcript)
27
DKA Rx EBM
  • In patients not in shock, recovery is more rapid
    with slower rates of IV fluids (500 mL/h x 4h,
    then 250 mL/h)
  • RCT Adrogue et al, 1989, JAMA 2622108-13
  • Low-dose insulin (0.1-0.2 U/Kg bolus, then rate
    of 0.1-0.2 U/Kg/h) has similar rate of recovery
    and less hypokalemia than high-dose insulin
    (50-150 U/h)
  • RCT Kitabchi et al, 1976, Ann Intern Med
    84633-8
  • RCT Heber et al, 1977, Arch Intern Med
    1371377-80
  • No clinical benefit to giving IV HCO3
  • RCT Gamba et al, 1991, Rev Invest Clin
    43234-48
  • No benefit to giving IV phosphate
  • RCT Fischer et al, 1983, JCEM57177-80

28
HONCHyperosmolar Non-Ketotic Coma
  • T2DM, elderly (mean age 60-73), F gt M
  • Pathogenesis poorly understood
  • Mild ECFv? instigating factor
  • Insulin/Glucagon ratio sufficient to limit DKA
  • Diminished thirst or access to water
  • Vicious cycle develops

29
HONC
30
HONC Diagnosis
  • Signs Symptoms
  • Polyuria, Polydipsia, fatigue x weeks/months
  • N/V (lt than in DKA)
  • Dehydration ? Overt Shock
  • Fever 50
  • Decreased LOC Confusion/Lethargy (40-50),
    Stupor or coma (27-54)
  • Laboratory
  • BS gt 33 mM, Serum OSM gt 320 mM
  • pH gt 7.3, HCO3 gt 20 mEq/L, Ketones negative
  • (33 cases mild DKA, hi-AG acidosis for other
    reasons)

31
HONC Precipitating Factors
Acute illness
(MI, GIB, trauma,
10-15
pancreatitis)
5-15
New-onset DM
33
Infection
40-60
Noncompliance
32
HONC Management
  • Coma Management
  • ABCs, O2, narcan, D50W, thiamine, etc.
  • Monitoring
  • IV Fluid Resusciation (10L free water defecit)
  • Insulin?
  • Potassium (Deficit 300-500 mEq)
  • Identify Rx underlying precipitant!

33
HONC Monitoring
  • ICU or Stepdown best
  • Vitals q1h
  • Lytes, creatinine, glucose q2-4h
  • Serum OSM, Urine OSM/USG
  • Cultures, EKG, cardiac enzymes
  • CT brain (R/O CVA, SDH, etc.)
  • Consider pulmonary embolism

34
HONC IV Fluids
  • 25 body water lost (deficit 4-12 L)
  • If hypotensive
  • Start with NS 1L/h x 1-2h
  • Once ECFv normal change to 1/2NS
  • IV 200-500 cc/h initially
  • Correct ½ deficit over 1st 12h
  • Correct total deficit by 36h
  • Lower fluid rates if elderly or known CHF

35
HONC Insulin?
  • Patients can be treated successfully without
    insulin
  • If IV fluids inadequate BS and serum OSM will not
    drop despite insulin
  • Majority of studies used insulin
  • Hi-dose Insulin severe hypokalemia, shock
  • Therefore if going to use insulin, use low doses
  • Bolus 0.1 U/kg, Rate 1-2 U/h (or 0.1 U/kg/h)

36
HONC Management
  • Coma Management
  • ABCs, O2, narcan, D50W, thiamine, etc.
  • Monitoring
  • IV Fluid Resusciation (10L free water defecit)
  • Insulin?
  • IV fluids will decrease BS by 4 mM/L/h by itself
  • For most patients insulin not absolutely
    neccesary
  • Insulin IV bolus 5-10 U, gtt _at_ 1-2 U/h
  • Potassium (Deficit 300-500 mEq)
  • Replace as in DKA
  • Identify Rx underlying precipitant!

37
HONC Prognosis
  • Hi-mortality
  • Earlier series 58
  • Recent studies 12-17 (but some with mixed DKA)
  • 30 complicating illness
  • LRTI, GI bleed, ARF, CVA, MI, Pulm embolism
  • DVT prophylaxsis beneficial?
  • Independent mortality predictors
  • Advanced age
  • High osmolality, elevated ureas
  • After recovery
  • Discharged on Insulin or OHA (I prefer insulin!)
  • Monitor closely for water intake/dehydration
    (especially nursing home patients)
Write a Comment
User Comments (0)
About PowerShow.com